Kip 25

An Emerging-Markets Fund Snaps Back

Few expected a post-COVID rally in emerging-markets stocks, in part because of a belief that developing countries wouldn’t cope well with the pandemic.

Emerging-markets stocks were beginning to recover in late 2019, thanks to a trade agreement between China and the U.S., when the pandemic upended everything. During the ensuing stock market sell-off, the MSCI Emerging Markets index fell 31%. Baron Emerging Markets (symbol BEXFX), a member of the Kiplinger 25, our list of favorite no-load mutual funds, lost 34%. No matter. Its recovery has been spectacular. The fund’s one-year return through mid August beat the index by more than three percentage points.

During the sell-off, manager Michael Kass sorted the fund’s portfolio into three groups: firms perceived to be beneficiaries of the disruption from COVID-19; firms that were adversely affected but would likely survive; and businesses likely to be “impaired” long term.

Then Kass added to holdings that were temporarily impacted, such as Reliance Industries, an Indian conglomerate that has become a dominant internet services provider, and Kingsoft, a Chinese cloud services and software company. He also beefed up or acquired stakes in firms deemed to be long-term COVID beneficiaries, including Brazilian digital payments providers PagSeguro and StoneCo. Many of these stocks have more than doubled since the sell-off.

Kass sold shares, too, including his entire stake in three airlines. A full recovery in airline travel could take three to five years, he says. “In a recession, a 10% decline in revenue is huge. These companies saw a 90% decline.”

Few expected a post-COVID rally in emerging-markets stocks, in part because of a belief that developing countries wouldn’t cope well with the pandemic. But Kass says stock markets in China, Korea and Taiwan “have performed the best coming out of the crisis because they efficiently managed” the virus.

Kass zeroes in on opportunities in growth-oriented themes such as e-commerce and digital payments, or local Chinese companies focusing on robotics and biotechnology, to name a few. Then he and his analysts do down-and-dirty research to pick stocks. Over the past five years, the formula has delivered a 6.9% annualized return, which beat both the MSCI EM index and the average diversified emerging-markets stock fund.

Most Popular

Planning to Sell Your Home in Retirement? Downsize Costs Along With Space
Budgeting

Planning to Sell Your Home in Retirement? Downsize Costs Along With Space

In this hot real estate market, consider the costs of buying and selling a house along with the expenses associated with your new digs.
November 13, 2020
What Biden Will Do: 24 Policy Plays to Expect From the Next Administration
Politics

What Biden Will Do: 24 Policy Plays to Expect From the Next Administration

The Kiplinger Letter forecasts President-Elect Joe Biden’s biggest priorities -- and the likelihood of progress on them.
November 19, 2020
The 13 Best Healthcare Stocks to Buy for 2021
Kiplinger's Investing Outlook

The 13 Best Healthcare Stocks to Buy for 2021

Most of the best healthcare stocks for 2021 will have some sort of ties to COVID, whether it's producing a vaccine or cure, or benefiting from the vir…
November 20, 2020

Recommended

Stock Market Today 12/1/20: Wall Street Hangs on Stimulus Hopes Again
stocks

Stock Market Today 12/1/20: Wall Street Hangs on Stimulus Hopes Again

A stimulus package brought by a group of nonpartisan senators Tuesday sparked stocks, which kept most of their gains even after the plan was shot down…
December 1, 2020
Stock Market Today 11/30/20: Dow Closes Out Best Month Since 1987
stocks

Stock Market Today 11/30/20: Dow Closes Out Best Month Since 1987

The major indices dipped Monday despite more positive COVID vaccine news, but the Dow nonetheless capped its best single-month performance in 33 years…
November 30, 2020
25 Stocks That Billionaires Sold in Q3 2020
Investor Psychology

25 Stocks That Billionaires Sold in Q3 2020

Billionaires and high-asset hedge funds dumped a number of holdings during 2020's third quarter. We look at which stocks they've soured on, and why.
November 30, 2020
Stock Market Today 11/27/20: Nasdaq Notches Another High as COVID's Spread Worsens
stocks

Stock Market Today 11/27/20: Nasdaq Notches Another High as COVID's Spread Worsens

An error in AstraZeneca's COVID-19 vaccine trial and persistent coronavirus troubles in the U.S. led investors to chase the old COVID trade Friday.
November 29, 2020